5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
US9187496B2 · kind B2 · utility
0Cited by
27References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2012 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | Nov 13, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06165
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.